Immune response in rabbit ovaries following infection of a recombinant myxoma virus expressing rabbit zona pellucida protein B.
D000818:Animals; D000906:Antibodies / Q000032:analysis / Q000276:immunology*; D000918:Antibody Specificity; D015551:Autoimmunity; D003269:Contraception, Immunologic; D005260:Female; D005822:Genetic Vectors; D007114:Immunization; D007070:Immunoglobulin A / Q000096:biosynthesis / Q000276:immunology*; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D008184:Luteal Cells / Q000473:pathology; D009233:Myxoma virus / Q000276:immunology / Q000378:metabolism*; D009865:Oocytes / Q000378:metabolism; D006080:Ovarian Follicle / Q000473:pathology; D010053:Ovary / Q000276:immunology* / Q000473:pathology; D011213:Poxviridae Infections / Q000097:blood / Q000276:immunology*; D011817:Rabbits; D011961:Receptors, Fc / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000473:pathology; D014614:Vaccines, Synthetic / Q000276:immunology; D015044:Zona Pellucida / Q000378:metabolism*
D000906:Antibodies; C045281:IgA receptor; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D011961:Receptors, Fc; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic